Helen Burstin, MD, MPH, MACP, Chief Executive Officer, Council of Medical Specialty Societies
Helen Burstin, MD, MPH, MACP is the Chief Executive Officer of the Council of Medical Specialty Societies (CMSS), a coalition of more than 50 specialty societies representing more than 800,000 physicians. As the national organization of specialty societies, CMSS advances the expertise and collective voice of medical specialty societies in support of physicians and the patients they serve. Representing specialties, from primary care to surgery, CMSS addresses critical issues across specialties through shared learning and innovation, convening, collaboration, and collective action.
Dr. Burstin formerly served as Chief Scientific Officer of The National Quality Forum (NQF). Prior to joining NQF, she was the Director of the Center for Primary Care, Prevention, and Clinical Partnerships at the Agency for Healthcare Research and Quality (AHRQ). Prior to joining AHRQ, Dr. Burstin was an Assistant Professor at Harvard Medical School and served as Director of Quality Measurement at Brigham and Women’s Hospital.
She is the author of more than 100 articles and book chapters on quality, safety, equity, and measurement. She serves on the American Society of Hematology Research Collaborative Board of Directors and the Oversight Committee of the National Cardiovascular Data Registry (NCDR) of the American College of Cardiology. She is the Vice-Chair of the Gender Equity in Academic Medicine and Science (GEMS) Alliance.
A graduate of the State University of New York at Upstate College of Medicine and the Harvard School of Public Health, Dr. Burstin completed her residency training in primary care internal medicine at Boston City Hospital and fellowship in General Internal Medicine and Health Services Research at Brigham and Women’s Hospital and Harvard Medical School. She is a volunteer preceptor and Clinical Professor of Medicine at George Washington University School of Medicine and Health Sciences. She is a member of the National Academy of Medicine.
Damon L. Davis, MBA, Associate Director, Alliance Development, Market Access and Public Affairs, Novo Nordisk, Inc.
Damon L. Davis, MBA is a former health innovation official at the U.S. Department of Health and Human Services (HHS) during the Obama administration. He currently serves patient interests in the Market Access and Public Affairs branch of Novo Nordisk, Inc. as the Associate Director of Alliance Development. At HHS, Davis led the Department’s efforts to promote policies and technology solutions to improve access to valuable health and scientific data resources. Overseeing HealthData.gov, he helped expand the uses of HHS data to drive innovative solutions to problems across the healthcare continuum.